We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
News

BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies

BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
News

BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The acquisition of KIESTRA Lab Automation BV, a Netherlands-based company that designs, develops, manufactures, markets and sells innovative lab automation solutions for the microbiology lab, complements BD’s microbiology portfolio of instruments, reagents and supplies.

“Microbiology labs are facing unprecedented challenges – including cost containment pressures and a shortage of qualified staff – while the need for faster delivery of more accurate results is increasing to ensure optimal patient care,” said Jamie Condie, Vice President and General Manager, BD Diagnostics – Diagnostic Systems. “The combination of BD’s broad portfolio of microbiology platforms, reagents and supplies with KIESTRA’s automated instrumentation technologies will enable us to offer a more comprehensive microbiology lab solution to hospitals and laboratories worldwide.”

KIESTRA offers two lines of automated solutions: Total Lab Automation (TLA) and Work Cell Automation (WCA).  KIESTRA developed the world’s first TLA solution for microbiology, KIESTRA, it's the sample that moves!®, in 2007 as a high throughput and customizable track-based system. Total Lab Automation is designed to significantly increase overall microbiology lab productivity, streamline workflow and shorten the time to results. KIESTRA’s Work Cell solutions will offer customers a modular and scalable approach to automate their lab within current space and budget constraints. KIESTRA currently has an installed base of instruments at public hospitals, universities and private labs in the Netherlands, Sweden, Germany, UK, France, Switzerland, Luxembourg, Denmark, Kuwait, Australia and New Zealand.

“We look forward to joining the BD team to expand automation across the entire microbiology and infectious disease testing process,” said Jetze Botma, Vice President, Microbiology Laboratory Automation, who served until the acquisition as CEO, KIESTRA Lab Automation.  “Together with BD, we now have the opportunity to integrate automation across microbiology informatics, instruments and consumables for maximum workflow efficiency, and have access to the global arena.”

Advertisement